FDANonrulemakingFDA-2023-D-4177
Who commented on this docket
Quality Considerations for Topical Ophthalmic Drug Products; Draft Guidance for Industry; Availability
2 organizations filed 2 public comments on Quality Considerations for Topical Ophthalmic Drug Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 883d ago.
Organizations
2
Comments
2
RIN
—
Comment window
closed 883d ago
Abstract
OPEN
Commenters (2)
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.